Statistics for Corbus Pharmaceuticals Holdings (id:5882 CRBP)

Valuation metrics

Market cap

204.13M

Enterprise value

46.55M

Trailing P/E (ttm)

-1.69

Forward P/E

-3.20

PEG ratio

-3.20

Price/Sales (ttm)

Price/Book (mrq)

1.36

Enterprise Value/Revenue

Enterprise Value/EBITDA

-1.02

Overview

Shares outstanding

12.18M

Float

8.49M

Shares short

2.38M

% Held by insiders

0.01%

% Held by institutions

1.07%

Average volume (10 days)

377.22K

Average volume (90 days)

Price summary

52-Week low

4.00

52-Week high

61.90

52-Week change

75.16%

Beta

2.56

50-Day moving average

24.63

200-Day moving average

39.01

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

February 14th, 2023

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-28.82%

Return on equity

-51.32%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-45,617,700.00

Net income to common (ttm)

-38,700,316.00

Diluted EPS (ttm)

-4.71

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

159.36M

Total cash per share (mrq)

13.08

Total debt (mrq)

3.61M

Total Debt/Equity (mrq)

2.40

Current ratio (mrq)

1.38K%

Book value per share (mrq)

12.36

Cash flow

Cash flow statement

-36,860,472.00

Levered free cash flow (LFCF)

-25,396,628.00